Eargo, which manufactures differentiated hearing aid techniques, submitted on Friday with the SEC to elevate up to $100 million in an preliminary general public presenting.
Eargo believes its listening to aids are the very first and only virtually invisible, rechargeable, completely-in-canal, FDA controlled, exempt Class I device for the treatment of hearing reduction. The corporation has sold more than 42,000 hearing assist devices, internet of returns, as of June 30, 2020.
The San Jose, CA-based mostly corporation was established in 2010 and booked $47 million in sales for the 12 months finished June 30, 2020. It designs to checklist on the Nasdaq under the symbol EAR. Eargo filed confidentially on November 8, 2019. J.P. Morgan, BofA Securities, Wells Fargo Securities and William Blair are the joint bookrunners on the deal. No pricing conditions were being disclosed.
The report Listening to assist maker Eargo information for a $100 million IPO originally appeared on IPO expense supervisor Renaissance Capital’s web website renaissancecapital.com.
Expenditure Disclosure: The information and facts and viewpoints expressed herein had been ready by Renaissance Capital’s exploration analysts and do not represent an supply to invest in or offer any security. Renaissance Capital’s Renaissance IPO ETF (image: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of organizations pointed out.
The sights and viewpoints expressed herein are the sights and thoughts of the creator and do not automatically replicate those of Nasdaq, Inc.